34 employees
Carbon Biosciences is a biotech company that engages in the novel parvovirus gene therapy.
2021
$38M
from 6 investors over 6 rounds
Carbon Biosciences raised $38M on June 21, 2022
Investors: Astellas Venture Capital L.L.C., Longwood Fund, Camford Capital, UTokyo Innovation Platform Co., Ltd., Solasta Ventures and Agent Capital